PDEF is a negative regulator of colon cancer cell growth and migration

Journal of Cellular Biochemistry

Volumn 108, Issue 6, 2009, Pages 1389-1398

  Moussa, Omar ^a,b   Turner, David P ^a,b   Feldman, Ron J ^a,b,c   Sementchenko, Victor I ^a,b,d   McCarragher, Brent D ^a,b   Desouki, Mohamedm ^a   Fraig, Mostafa ^a,b,e   Watson, Dennis K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NuGEN Technologies Inc   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell growth; Colon cancer; ETS; Migration; PDEF; Transcription factors

Indexed keywords

BIOLOGICAL FACTOR; MESSENGER RNA; PROSTATE DERIVED ETS FACTOR; PROTEIN P21; UNCLASSIFIED DRUG; UROKINASE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; TUMOR GROWTH;

CACO-2 CELLS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; HUMANS; PROTO-ONCOGENE PROTEINS C-ETS; RNA, MESSENGER; THIOREDOXINS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 71749088416     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22371     Document Type: Article

References (36)

1. Barker N, van de Wetering M, Clevers H. 2008. The intestinal stem cell. Genes Dev 22:1856-1864.
2. Beier F, Taylor AC, LuValle P. 1999. The Raf-1/MEK/ERK pathway regulates the expression of the p21(Cip1/Waf1) gene in chondrocytes. J Biol Chem 274:30273-30279. (Pubitemid 29483418)
3. Carbone GM, Napoli S, Valentini A, Cavalli F, Watson DK, Catapano CV. 2004. Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells. Nucleic Acids Res 32:4358-4367. (Pubitemid 39232308)
4. Cheng K, Xie G, Raufman JP. 2007. Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line. Biochem Pharmacol 73:1001-1012. (Pubitemid 46283578)
5. Cohen GM. 1997. Caspases: The executioners of apoptosis. Biochem J 326:1-16.
6. D'Orazio D, Besser D, Marksitzer R, Kunz C, Hume DA, Kiefer B, Nagamine Y. 1997. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201:179-187. (Pubitemid 27504092)
7. Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK. 2003a. PDEF expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res 63:4626-4631. (Pubitemid 36951040)
8. Feldman RJ, Sementchenko VI, Watson DK. 2003b. The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation, and carcinogenesis. Anticancer Res 23:2125-2132.
9. Findlay VJ, Turner DP, Moussa O, Watson DK. 2008. MicroRNA-mediated inhibition of PDEF mRNA translation affects PDEF regulatory networks in human breast cancer. Cancer Res 68:8499-8506.
10. Funaoka K, Shindoh M, Yoshida K, Hanzawa M, Hida K, Nishikata S, Totsuka Y, Fujinaga K. 1997. Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF. Biochem Biophys Res Commun 236:79-82. (Pubitemid 27341843)
11. Ghadersohi A, Pan D, Fayazi Z, Hicks DG, Winston JS, Li F. 2007. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo. Breast Cancer Res Treat 102:19-30. (Pubitemid 46306111)
12. Ghadersohi A, Odunsi K, Zhang S, Azrak RG, Bundy BN, Manjili MH, Li F. 2008. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. Int J Cancer 123:1376-1384.
13. Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grall F, Onatunde T, Correa RG, Libermann TA. 2007. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res 67:4219-4226. (Pubitemid 46815068)
14. Ito Y, Takeda T, Okada M, Matsuura N. 2002. Expression of ets-1 and ets-2 in colonic neoplasms. Anticancer Res 22:1581-1584. (Pubitemid 34839167)
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
16. Kioi M, Yamamoto K, Higashi S, Koshikawa N, Fujita K, Miyazaki K. 2003. Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 22:8662-8670. (Pubitemid 38010489)
17. Liu W, Wang G, Yakovlev AG. 2002. Identification and functional analysis of the rat caspase-3 gene promoter. J Biol Chem 277:8273-8278. (Pubitemid 34968286)
18. Mitas M, Mikhitarian K, Hoover L, Lockett MA, Kelley L, Hill A, Gillanders WE, Cole DJ. 2002. Prostate-specific Ets (PSE) factor: A novel marker for detection of metastatic breast cancer in axillary lymph nodes. Br J Cancer 86:899-904. (Pubitemid 34271025)
19. Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A. 2005. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem Biophys Res Commun 333:1011-1016. (Pubitemid 40854257)
20. Ng AY, Waring P, Ristevski S, Wang C, Wilson T, Pritchard M, Hertzog P, Kola I. 2002. Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. Gastroenterology 122:1455-1466. (Pubitemid 34465186)
21. Nowak DE, Tian B, Brasier AR. 2005. Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques 39:715-725.
22. Nozawa M, Yomogida K, Kanno N, Nonomura N, Miki T, Okuyama A, Nishimune Y, Nozaki M. 2000. Prostate-specific transcription factor hPSE is translated only in normal prostate epithelial cells. Cancer Res 60:1348-1352. (Pubitemid 30152005)
23. Oettgen P, Finger E, Sun Z, Akbarali Y, Thamrongsak U, Boltax J, Grall F, Dube A, Weiss A, Brown L, Quinn G, Kas K, Endress G, Kunsch C, Libermann TA. 2000. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J Biol Chem 275:1216-1225. (Pubitemid 30051174)
24. Park JS, Qiao L, Gilfor D, Yang MY, Hylemon PB, Benz C, Darlington G, Firestone G, Fisher PB, Dent P. 2000. A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell 11:2915-2932. (Pubitemid 32107074)
25. Ploplis VA, Tipton H, Menchen H, Castellino FJ. 2007. A urokinase-type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice. J Pathol 213:266-274. (Pubitemid 350074016)
26. Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S. 2004. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 19:518-524. (Pubitemid 39445406)
27. Sementchenko VI, Watson DK. 2000. Ets target genes: Past, present and future. Oncogene 19:6533-6548. (Pubitemid 32108443)
28. Seth A, Watson DK. 2005. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41:2462-2478. (Pubitemid 41540623)
29. Soldatenkov VA, Albor A, Patel BK, Dreszer R, Dritschilo A, Notario V. 1999. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor. Oncogene 18:3954-3962. (Pubitemid 29361333)
30. Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben- David Y. 1999. Fli-1, an Ets-related transcription factor, regulates erythropoietin- induced erythroid proliferation and differentiation: Evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 19:4452-4464. (Pubitemid 29242019)
31. Turner DP, Watson DK. 2008. ETS transcription factors: Oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther 8:33-42.
32. Turner DP, Findlay VJ, Moussa O, Watson DK. 2007a. Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem 102:549-559. (Pubitemid 47557410)
33. Turner DP, Moussa O, Sauane M, Fisher PB, Watson DK. 2007b. Prostatederived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Cancer Res 67:1618-1625. (Pubitemid 46383387)
34. Turner DP, Findlay VJ, Kirven AD, Moussa O, Watson DK. 2008. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell 19: 3745-3757.
35. van den Brink GR, Offerhaus GJ. 2007. The morphogenetic code and colon cancer development. Cancer Cell 11:109-117.
36. Zlobec I, Minoo P, Baumhoer D, Baker K, Terracciano L, Jass JR, Lugli A. 2008. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Cancer 112:495-502. (Pubitemid 351186190)